Is Nukkleus Stock a Good Investment?
Nukkleus Investment Advice | NUKKW |
- Examine Nukkleus' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Nukkleus' leadership team and their track record. Good management can help Nukkleus navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Application Software space and any emerging trends that could impact Nukkleus' business and its evolving consumer preferences.
- Compare Nukkleus' performance and market position to its competitors. Analyze how Nukkleus is positioned in terms of product offerings, innovation, and market share.
- Check if Nukkleus pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Nukkleus' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Nukkleus stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Nukkleus is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Average | Details | |
Economic Sensitivity | Moves completely opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Nukkleus Stock
Researching Nukkleus' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 0.02. Nukkleus had not issued any dividends in recent years.
To determine if Nukkleus is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Nukkleus' research are outlined below:
| Nukkleus generated a negative expected return over the last 90 days | |
| Nukkleus has some characteristics of a very speculative penny stock | |
| Nukkleus has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 16.22 M. Net Loss for the year was (11.85 M) with profit before overhead, payroll, taxes, and interest of 502.52 K. | |
| Latest headline from news.google.com: Nukkleus Shares Are Soaring After Hours Heres Why - Benzinga |
Nukkleus Quarterly Accounts Payable |
|
Nukkleus' market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.22 B.Market Cap |
|
Nukkleus' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.41) | (1.48) | |
| Return On Capital Employed | (1.18) | (1.12) | |
| Return On Assets | (0.79) | (0.83) | |
| Return On Equity | (1.71) | (1.62) |
Determining Nukkleus' profitability involves analyzing its financial statements and using various financial metrics to determine if Nukkleus is a good buy. For example, gross profit margin measures Nukkleus' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Nukkleus' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Nukkleus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nukkleus. Check Nukkleus' Beneish M Score to see the likelihood of Nukkleus' management manipulating its earnings.
Evaluate Nukkleus' management efficiency
Nukkleus has return on total asset (ROA) of (1.1502) % which means that it has lost $1.1502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7499) %, meaning that it generated substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.48 in 2025. Return On Capital Employed is likely to climb to -1.12 in 2025. At this time, Nukkleus' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 4.5 M in 2025, whereas Non Currrent Assets Other are likely to drop (13.9 M) in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.00 | 1.05 | |
| Tangible Book Value Per Share | 0.33 | 0.35 | |
| Enterprise Value Over EBITDA | (47.94) | (50.34) | |
| Price Book Value Ratio | 48.78 | 51.21 | |
| Price Fair Value | 48.78 | 51.21 | |
| Enterprise Value Multiple | (47.94) | (50.34) | |
| Enterprise Value | 534.1 M | 273.9 M |
Understanding the management dynamics of Nukkleus allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Beta (0.32) |
Basic technical analysis of Nukkleus Stock
As of the 26th of January, Nukkleus secures the Standard Deviation of 24.12, risk adjusted performance of 0.0729, and Mean Deviation of 5.52. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nukkleus, as well as the relationship between them. Please verify Nukkleus variance to decide if Nukkleus is priced some-what accurately, providing market reflects its recent price of 0.0301 per share. As Nukkleus appears to be a penny stock we also strongly suggest to check its information ratio numbers.Understand Nukkleus' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Nukkleus' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0729 | |||
| Market Risk Adjusted Performance | (0.84) | |||
| Mean Deviation | 5.52 | |||
| Coefficient Of Variation | 1335.9 | |||
| Standard Deviation | 24.12 | |||
| Variance | 581.91 | |||
| Information Ratio | 0.0726 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | 0.5029 | |||
| Treynor Ratio | (0.85) | |||
| Maximum Drawdown | 183.96 | |||
| Skewness | 6.5 | |||
| Kurtosis | 52.7 |
| Risk Adjusted Performance | 0.0729 | |||
| Market Risk Adjusted Performance | (0.84) | |||
| Mean Deviation | 5.52 | |||
| Coefficient Of Variation | 1335.9 | |||
| Standard Deviation | 24.12 | |||
| Variance | 581.91 | |||
| Information Ratio | 0.0726 | |||
| Jensen Alpha | 1.89 | |||
| Total Risk Alpha | 0.5029 | |||
| Treynor Ratio | (0.85) | |||
| Maximum Drawdown | 183.96 | |||
| Skewness | 6.5 | |||
| Kurtosis | 52.7 |
Consider Nukkleus' intraday indicators
Nukkleus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nukkleus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0301 | |||
| Day Typical Price | 0.0301 |
Nukkleus Stock media impact
Far too much social signal, news, headlines, and media speculation about Nukkleus that are available to investors today. That information is available publicly through Nukkleus media outlets and privately through word of mouth or via Nukkleus internal channels. However, regardless of the origin, that massive amount of Nukkleus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Nukkleus news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Nukkleus relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Nukkleus' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Nukkleus alpha.
Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.